HCA Healthcare AI Stock Analysis
Want to see HCA full AI Analyst Report?
HCA Healthcare (HCA) AI Stock Analysis
HCA Healthcare
(NYSE:HCA)
The score is anchored by strong technical momentum and a constructive earnings outlook with resilient volumes and cost control. This is offset by elevated balance-sheet risk (high leverage and negative equity) and policy/payer-mix headwinds (exchange disenrollment and reduced Medicaid supplemental payments expected in 2027). Valuation is reasonable on P/E but offers limited support from a low dividend yield.
HCA Healthcare Key Performance Indicators (KPIs)
Adjusted EBITDA by SegmentHighlights profitability across different business units, providing insight into which segments drive earnings and where operational efficiencies or challenges lie.
The operating groups delivered steady multi‑year EBITDA expansion (with typical Q4 strength), but the recent sequential pullback into early 2026 and a deeper, more volatile Corporate & Other drag show margins are under strain. Management attributes near‑term weakness to a concentrated payer‑mix shock from exchange disenrollment (a material EBITDA hit in Q2) partially offset by Medicaid supplemental payments; the company is leaning on cost‑resiliency programs and buybacks, so future upside depends on policy stabilization and successful execution of those savings initiatives.
HCA Healthcare (HCA) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $99.34B
- Dividend Yield
- 0.64%
- Average Volume (3M)
- 1.36M
- Price to Earnings (P/E)
- 15.7
- Beta (1Y)
- 0.27
- Revenue Growth
- 5.82%
- EPS Growth
- 16.59%
- Country
- US
- Employees
- 320,000
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Care Facilities
HCA Healthcare Business Overview & Revenue Model
Company Description
HCA Healthcare, Inc., operating through its subsidiaries, delivers a comprehensive array of healthcare services throughout the United States. The organization manages a network of general and acute care hospitals that provide a full spectrum of medic...
How the Company Makes Money
HCA makes money primarily by delivering healthcare services and being reimbursed for those services by third-party payers and patients. Its core revenue stream is patient service revenue generated when patients receive care at HCA facilities (e.g., a...
HCA Healthcare Earnings Call Summary
The call was positive overall. HCA reported continued volume growth, improved revenue per admission, solid cost performance, strong cash flow, share repurchases, a strong balance sheet, and guidance toward the upper half of its 2026 ranges. These positives outweighed significant but acknowledged challenges from exchange-related payer-mix deterioration, declining elective surgical volumes, higher professional fees, and lower expected Medicaid supplemental payment benefits in 2027.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
For 2027, HCA expects demand to remain strong, with volume growth forecasted to be 2% to 3%; it expects approximately $550 million to $650 million less in Medicaid supplemental payment net benefits, anticipates favorable cost performance primarily due to its ongoing enterprise wide resiliency program and operating leverage from expected volume growth, and anticipates earnings will be generally consistent with 2026. Beyond 2027, performance is expected to be more in line with long term growth targets, assuming the company moves past the most significant effects on payer mix from the exchanges, assumes no material policy changes beyond HR1, and strategic initiatives generate significant value. For 2026, guidance ranges were reaffirmed, with results currently expected to be in the upper half of those ranges; incremental net benefits from Medicaid supplemental payment programs are expected to be between $600 million and $800 million, while the full year unfavorable impact on adjusted EBITDA from payer mix shifts is expected to be at or slightly above the upper end of the range of previously updated guidance.
HCA Healthcare Financial Statement Overview
Summary
Operating performance is solid (Income Statement Score 74) with multi-year revenue growth and healthy profitability, and cash generation is positive (Cash Flow Score 61) though recently softer. The major offset is the balance sheet (Balance Sheet Score 28): rising debt and persistently negative equity reduce financial flexibility and raise risk if conditions tighten.
Income Statement
74PositiveBalance Sheet
28NegativeCash Flow
61Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 78.70B | 75.60B | 70.60B | 64.97B | 60.23B | 58.75B |
| Gross Profit | 17.07B | 31.37B | 28.68B | 25.58B | 23.18B | 22.49B |
| EBITDA | 15.90B | 15.60B | 13.90B | 12.72B | 13.29B | 14.25B |
| Net Income | 6.78B | 6.78B | 5.76B | 5.24B | 5.64B | 6.96B |
Balance Sheet | ||||||
| Total Assets | 63.45B | 60.72B | 59.51B | 56.21B | 52.44B | 50.74B |
| Cash, Cash Equivalents and Short-Term Investments | 908.00M | 1.04B | 2.02B | 935.00M | 908.00M | 1.45B |
| Total Debt | 52.43B | 50.20B | 45.24B | 41.86B | 40.20B | 36.73B |
| Total Liabilities | 68.05B | 63.49B | 58.96B | 55.15B | 52.51B | 49.25B |
| Stockholders Equity | -8.08B | -6.03B | -2.50B | -1.77B | -2.77B | -933.00M |
Cash Flow | ||||||
| Free Cash Flow | 5.97B | 7.69B | 5.64B | 4.69B | 4.13B | 5.38B |
| Operating Cash Flow | 11.17B | 12.64B | 10.51B | 9.43B | 8.52B | 8.96B |
| Investing Cash Flow | -6.07B | -4.99B | -4.93B | -5.32B | -3.39B | -2.64B |
| Financing Cash Flow | -5.18B | -8.55B | -4.58B | -4.09B | -5.66B | -6.66B |
HCA Healthcare Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HCA, the sentiment is Positive. The current price of 475.57 is below the 20-day moving average (MA) of 485.69, above the 50-day MA of 459.71, and above the 200-day MA of 443.86, indicating a neutral trend. The MACD of 7.03 indicates Positive momentum. The RSI at 48.88 is Neutral, neither overbought nor oversold. The STOCH value of 12.75 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HCA.
HCA Healthcare Risk Analysis
HCA Healthcare disclosed 62 risk factors in its most recent earnings report. HCA Healthcare reported the most risks in the "Legal & Regulatory" category.
Latest Risks Added
3 New RisksHCA Healthcare Peers Comparison
Overall Rating
THC87Outperform
UHS76Outperform
ENSG75Outperform
EHC70Outperform
HCA67Neutral
CYH42Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 87Outperform | $20.98B | 7.58 | 60.60% | ― | 6.23% | 136.09% | |
| 76Outperform | $10.09B | 7.44 | 19.54% | 0.45% | 8.00% | 13.14% | |
| 75Outperform | $10.30B | 25.52 | 16.63% | 0.15% | 17.49% | 19.82% | |
| 70Outperform | $12.98B | 20.63 | 25.17% | 0.58% | 9.36% | 20.78% | |
| 67Neutral | $96.16B | 15.71 | -100.45% | 0.64% | 5.82% | 16.59% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 42Neutral | $227.05M | 6.00 | -2.51% | ― | -7.84% | -88.93% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| HCA | Hca Healthcare | 475.57 | -22.07 | -4.43% | |
| CYH | Community Health Systems | 1.62 | -1.77 | -52.21% | |
| EHC | Encompass Health | 133.65 | 21.35 | 19.01% | |
| THC | Tenet Healthcare Corp. | 263.19 | 48.57 | 22.63% | |
| ENSG | The Ensign | 176.32 | -7.99 | -4.33% | |
| UHS | Universal Health Services | 179.43 | -56.49 | -23.95% |
HCA Healthcare Corporate Events
HCA Healthcare Announces Senior Notes Offering, Plans Redemption
NeutralOn November 2, 2026, HCA Healthcare announced that its direct, wholly owned subsidiary, HCA Inc., had commenced a proposed public offering of senior unsecured notes. The release said the notes’ maturity, interest rate and principal amount would be de...
HCA Healthcare posts solid Q3 results, maintains guidance
PositiveHCA Healthcare, Inc. is a large U.S.-based healthcare services provider that operates 189 hospitals and about 2,600 ambulatory sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics, across 1...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 05, 2026
